Back to BARCLAYS PLC BARCLAYS PLC

NKTRNKTR
5 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in Nektar Therapeutics

BARCLAYS PLC holds 262,362 shares of NKTR (Nektar Therapeutics), worth $18.3M as of 2026-Q2. The position was increased (+710.9% shares). NKTR represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$18.3M

Current Shares

262,362

Total Value Change

+$18.1M

Total Shares Change

+253,353

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
262,362
+710.9%
$18.3M0.0%$69.81
46
2026-Q1
Increased
32,356
+109.5%
$2.3M0.0%$68.11
42
2025-Q4
Decreased
15,444
-7.4%
$652,9720.0%$41.90
0
2025-Q3
Increased
16,679
+85.1%
$949,0350.0%$58.92
39
2025-Q2
New
9,009
-
$232,7930.0%$25.76
32

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used